Showing results (691-700 of 1,644) with videos related to
Sort By:
Pageof 165
Archives of Dermatological Research|November 6, 2022
The impact of complete clearance and almost complete clearance of psoriasis on quality of life: a literature reviewNicole D Boswell, Madison K Cook, Esther A Balogh, et al.Dermatologic Therapy|September 22, 2022
Reducing costs in atopic dermatitisElisha M Myers, Patrick O Perche, Joseph L Jorizzo, et al.Cutis|September 1, 1994
Focal myositis in a patient with bilateral painful nodulesN V Coots, J M Baunchalk, A R Feldman, et al.Expert Opinion on Emerging Drugs|March 21, 2020
Emerging systemic drugs in the treatment of plaque psoriasisEsther A Balogh, Arjun M Bashyam, Rima I Ghamrawi, et al.Expert Opinion on Pharmacotherapy|March 27, 2020
An evaluation of baricitinib as a therapeutic option for adult patients with moderate to severe atopic dermatitisJocelyn T Mendes, Esther A Balogh, Lindsay C Strowd, et al.The Journal of Dermatological Treatment|September 5, 2020
Treatment of keratosis pilaris and its variants: a systematic reviewJalal Maghfour, Sophia Ly, Wasim Haidari, et al.Journal of Managed Care & Specialty Pharmacy|May 28, 2016
Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United StatesAlain Taieb, Linda Stein Gold, Steven R Feldman, et al.The Journal of Dermatological Treatment|June 14, 2017
The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasisAli Rajabi-Estarabadi, Hournaz Hasanzadeh, Arash Taheri, et al.Expert Opinion on Drug Metabolism & Toxicology|August 24, 2018
Pharmacokinetics of tazarotene and acitretin in psoriasisMichael S Heath, Dev R Sahni, Zachary A Curry, et al.Journal of Medical Economics|June 6, 2017
Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costsCarl V Asche, Minchul Kim, Steven R Feldman, et al.Pageof 165